On June 14, 2019, China&39;s SAMR issued an announcement opening the public consultation period on a draft of &39;Clinical Trial Technique Guidelines of Full Nutritiferrous sulfate 220 mg/5ml liquid dosageon Formulas for Diabetes (Consultation Draft)[1]’, together with aferrous gluconate or ferrous fumaratenother two guidelines for patients with kidney disease and for patients with malijamieson gentle iron 28 mg ferrous bisglycinategnant tumors. Comments nenature made ferrous gluconateed to be submitted to the Specisynthesis of ferric pyrophosphateal Foods Division of SAMR by July 15, 2019.
SAMR Issues FSMP Clinical Trial Guidelines and Assessment Criteria
